Research Article
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
Table 3
Overall survival (OS) rate of stages I and II melanoma patients according to MIA serum concentration.
| MIA ng/mL | Number of patients | Number of deaths | 1-year OS | 2-year OS | 3-year OS | 4-year OS | Mean OS (95% CI) | Median OS (95% CI) |
| ≥9.4 | 24 | 14 | 87.5% | 62.5% | 43.8% | 38.9% | 2.9 years 2.3–3.6 | 2.9 years 1.7–4.0 | <9.4 | 60 | 3 | 98.3% | 96.2% | 93.3% | 93.3% | 4.4 years 4.1–4.6 | — |
|
|